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Abstract
Upon viral infection, mitochondrial antiviral signaling (MAVS) protein serves as a key adaptor to promote cytokine
production. We report here that murine gamma herpesvirus 68 (cHV68), a model virus for oncogenic human gamma
herpesviruses, subverts cytokine production via the MAVS adaptor. During early infection, cHV68 hijacks MAVS and IKKb to
induce the site-specific phosphorylation of RelA, a crucial subunit of the transcriptionally active NFkB dimer, which primes
RelA for the proteasome-mediated degradation. As such, cHV68 efficiently abrogated NFkB activation and cytokine gene
expression. Conversely, uncoupling RelA degradation from cHV68 infection promoted NFkB activation and elevated
cytokine production. Loss of MAVS increased cytokine production and immune cell infiltration in the lungs of cHV68-
infected mice. Moreover, exogenous expression of the phosphorylation- and degradation-resistant RelA variant restored
cHV68-induced cytokine production. Our findings uncover an intricate strategy whereby signaling via the upstream MAVS
adaptor is intercepted by a pathogen to nullify the immediate downstream effector, RelA, of the innate immune pathway.
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Introduction
Innate immunity represents the first line of defense against
invading pathogens. Eukaryotic cells express a panel of sensors,
known as pattern recognition receptors (PRRs), which detect
pathogen-associated molecular patterns that are either structural
components or replication intermediates [1,2]. Toll-like receptors
are primarily expressed on immune cells and patrol the
extracellular and endosomal compartments. The recently discov-
ered cytosolic receptors (e.g., NOD-like receptors and RIG-I-like
receptors) are more ubiquitously expressed and monitor the
presence of pathogens in the cytosol. Along with C-type lectins [3],
these sentinel molecules constitute the vast majority of PRRs in
high eukaryotes.
The cytosolic RIG-I and MDA-5 sensors are authentic RNA
helicases that contain two tandem caspase-recruitment domains
(CARD) within the amino-terminus and an RNA-binding domain
within the carboxyl terminus, endowing the ability to detect
nucleic acids [4,5]. Association with RNA triggers the dimeriza-
tion of RIG-I and MDA-5 with the mitochondrial antiviral
signaling (MAVS, also known as IPS-1, VISA, and CARDIF)
adaptor via their N-terminal CARDs, which relays signal to
promote antiviral cytokine production [6,7,8,9]. In doing so,
MAVS activates the IKKa/b/c and TBK1/IKKe kinase
complexes that, through phosphorylation, effectively promote the
gene expression driven by transcription factors of the NFkB
and interferon regulatory factor (IRF) family, respectively
[10,11,12,13]. It is believed that NFkB activation sufficiently
induces the expression of inflammatory cytokines, such as IL6 and
TNFa. The efficient transcriptional activation of a prototype
interferon (IFN), IFN-b, requires the concerted action of multiple
transcription factors including NFkB, ATF2, c-Jun, and IRFs,
constituting one of the most sophisticated coordination within
multiple innate immune signaling pathways to achieve optimal
antiviral immune responses [14,15]. The participation of numer-
ous components in relaying signaling from pathogen detection to
cytokine production maximizes the number of checkpoints to tune
host immune responses. Conversely, the highly ordered architec-
ture of signaling cascades also offers pathogens with opportunities
to manipulate and exploit host immune responses. Key to the
immune signaling cascades is the activation of NFkB transcription
factors that control cytokine production, an essential determinant
underlying effective host innate and adaptive immune responses.
The family of NFkB transcription factors is composed of five
members, including RelA (p65), RelB, c-Rel, NFkB1 (p50 derived
from its precursor p100), and NFkB2 (p52 derived from its
precursor p105) [16]. All NFkB transcription factors share an N-
terminal Rel homology domain that is responsible for subunit
dimerization and sequence-specific DNA binding activity. Addi-
tionally, RelA, RelB, and c-Rel harbor a C-terminal transcription
PLoS Pathogens | www.plospathogens.org 1 November 2011 | Volume 7 | Issue 11 | e1002336activation domain (TAD) that positively regulates gene transcrip-
tion. Among them, RelA is the most ubiquitously and abundantly
expressed subunit. By contrast, NFkB1 and NFkB2 do not contain
a TAD and therefore rely on dimerization with one of the other
three NFkB members to activate gene transcription. Furthermore,
post-translational modifications, such as phosphorylation and
acetylation, have been identified to confer specific effect on the
DNA-binding, protein stability, and transcriptional activity of
NFkB transcription factors [17,18]. Although the signaling
pathways that activate NFkB transcription factors have been
extensively investigated, relatively little is known regarding the
equally important process of NFkB termination.
Herpesviruses are large DNA viruses that establish a lifelong
persistent infection. To persist within immuno-competent hosts,
gamma herpesviruses in particular have evolved an arsenal of
weapons to contend with host immune responses [19,20]. Being
closely-related to human oncogenic Kaposi’s sarcoma-associated
herpesvirus (KSHV) and Epstein-Barr virus (EBV), murine
gamma herpesvirus 68 (cHV68) infects laboratory strains of mice,
resulting in robust acute infection in the lung and persistent
infection in the spleen. Thus, murine infection with cHV68 offers
a tractable small animal model to examine the entire course of host
immune responses and viral infection in vivo, which are not
available for human KSHV and EBV [21].
To assess the role of immune signaling pathways downstream of
cytosolic sensors in gamma herpesvirus infection, we have character-
ized viral infection and host innate immune responses in MAVS-
deficient mice infected with cHV68. We previously reported that
cHV68 activates the MAVS-IKKb pathway to promote viral lytic
infection [22]. Paradoxically, the activation of the MAVS-IKKb
pathway often instigates NFkB activation and the production of
antiviral cytokines [23,24]. Moreover, RelA was shown to inhibit
cHV68 lytic replication [25]. We report here that cHV68 utilizes
MAVS and IKKb to promote RelA phosphorylation and transient
degradation, thereby efficiently abrogating NFkB activation and
cytokine production. Finally, loss of MAVS elevated inflammatory
cytokines and immune cell infiltration in the lung of cHV68-infected
mice, highlighting an essential role of MAVS in evading antiviral
cytokine production. Our findings illustrate an intricate strategy
whereby a pathogen usurps upstream immune signaling events of the
NFkB pathway to destroy the essential downstream effector, RelA,
effectively nullifying host innate cytokine production. These findings
reshape our view on host innate immune responses.
Results
Loss of MAVS Results in Increased Cytokine Production in
Response to cHV68 Infection
We have previously shown that cHV68 loads in the lung of
Mavs
2/2 mice were significantly lower than those in the lung of
Mavs
+/+ mice at 10 d.p.i. [22]. We reasoned that the reduced
cHV68 acute infection may be, at least partly, due to an elevated
immune response in Mavs
2/2 mice. To test this hypothesis, we
measured inflammatory cytokines, including CCL5, CXCL1, IL6
and TNFa in Mavs
+/+ and Mavs
2/2 littermate mice infected with
a low-dose (40 plaque-forming units, PFU) cHV68 by enzyme-
linked immunosorbent assay (ELISA). A low dose infection more
likely resembles natural cHV68 infection. We found that, in
response to cHV68 infection, levels of all four cytokines in the
lung of Mavs
2/2 mice were approximately two-fold of those in
the lung of Mavs
+/+ mice at 7, 10, and 13 d.p.i. (Figure 1A). This
phenomenon is in stark contrast to the observations that loss of
MAVS impairs cytokine production in response to viral infection,
e.g., RNA viruses [23,24]. It is notable that cHV68 infection
induced significant cytokines in Mavs
2/2 mice at 7 d.p.i., when
cytokines were slightly reduced or unchanged in Mavs
+/+ mice,
indicating a faster cytokine production. Interestingly, cytokine
levels in the sera of cHV68-infected Mavs
+/+ and Mavs
2/2 mice
were similar (Figure S1A). There was no statistically significant
difference of IL10, an important anti-inflammatory cytokine, in
either lungs or sera of cHV68-infected Mavs
+/+ and Mavs
2/2
mice (Figures S1A, S1B). Consistent with our previous reported
result [22], loss of MAVS greatly reduced cHV68 load at 10
d.p.i. in the lung, whereas had a marginal effect on viral load at 7
d.p.i. (Figure 1B). These results collectively indicate that, in
response to cHV68 infection, Mavs
2/2 mice produce more
inflammatory cytokines specifically in the lung than Mavs
+/+
mice.
It was reported that cHV68 replicates to similar levels in
IL6-deficient and wild-type mice, implying that IL6 is not
obligate to limit cHV68 lytic replication [26]. However, our
study suggests that cHV68 successfully abrogates cytokine
production during early viral infection, the critical stage for
cytokines to curtail viral replication. As such, we reasoned that
obliterating IL6 does not enhance cHV68 lytic replication, and
that the administration of exogenous cytokines likely better
evaluates the effect of cytokines on cHV68 acute infection.
Thus, we intranasally administered recombinant mouse IL6 or
TNFa (rmIL6 or rmTNFa) after a low-dose (40 PFU/mouse)
cHV68 infection. We determined that the optimal efficiency of
intranasal delivery was approximately 60% (Figure S2).
Treatment with either rmIL6 or rmTNFa reduced cHV68
loads in the lung to less than 5% of those in mock-treated mice,
demonstrating the potent antiviral effect of rmIL6 and
rmTNFa against cHV68 (Figure 1C). Importantly, we found
that cytokine treatment did not affect mouse body weight
(Figure S3A), spleen mass (Figure S3B), or lung cytokine levels
(Figures S3C,S3D), excluding the potential side effect brought
by rmIL6 and rmTNFa treatment. Furthermore, we deter-
mined whether rmIL6 and rmTNFa inhibit cHV68 lytic
replication ex vivo under normal productive infection and
restricted condition (in methylcellulose-containing medium).
Under both conditions, treatment with rmIL6 and rmTNFa
reduced cHV68 yield by 60% (Figure 1D) and plaque-forming
units by 50% (Figure 1E). Collectively, these results bolster the
conclusion that inflammatory cytokines, such as IL6 and TNFa,
are potent antiviral effectors against cHV68 lytic replication ex
vivo and in vivo.
Author Summary
Innate immunity represents the first line of defense against
invading pathogens chiefly through anti-viral cytokines.
The mitochondrial antiviral signaling (MAVS)-dependent
innate immune pathways are critical for inflammatory
cytokine production. Deficiency in essential innate im-
mune components, such as MAVS, severely impairs
cytokine production and host defense that are enabled
by the master transcription factor, NFkB. Here we show
that murine gamma herpesvirus 68 (cHV68), a model
herpesvirus for human Kaposi’s sarcoma-associated her-
pesvirus and Epstein-Barr virus, hijacks MAVS and IKKb
to abrogate NFkB activation and cytokine production.
Uncoupling RelA degradation from cHV68 infection
restored NFkB-dependent cytokine gene expression and
elevated cytokine production. Thus, our results demon-
strate that upstream innate immune activation can be
harnessed by pathogens to inactivate the downstream
effector and subvert cytokine production.
Viral Hijacking of Host Innate Signal Transduction
PLoS Pathogens | www.plospathogens.org 2 November 2011 | Volume 7 | Issue 11 | e1002336Figure 1. MAVS deficiency increases inflammatory cytokines in the lung of cHV68-infected mice. (A and B) Age- and gender-matched
Mavs
+/+ and Mavs
2/2 littermate mice (n=8) were intranasally infected with 40 plaque-forming units (PFU) of cHV68. (A) Increased inflammatory
cytokines in the lung of cHV68-infected Mavs
2/2 mice compared with Mavs
+/+ mice. (B) cHV68 loads in the lung of infected mice were determined by
a plaque assay and shown in comparison to CCL5 levels. Data are presented as the mean 6 the standard error of the mean (SEM) of eight mice. See
also Figure S1. (C) Age- and gender-matched BL6 mice (n=8) were intranasally infected with 40 PFU of cHV68. Saline buffer, recombinant mouse IL6
or TNFa (rmIL6 or rmTNFa, 30 ng/mouse/day) was intranasally administered from 1 to 5 days post-infection (d.p.i.). Viral loads in the lung were
determined by a plaque assay at 6 d.p.i. See also Figure S2 and Figure S3. (D and E) Wild-type mouse embryonic fibroblasts (MEFs) were infected with
cHV68 at a multiplicity-of-infection (MOI) of 0.01 (D) or 0.005 (E), with or without rmIL6 or rmTNFa treatment (2 ng/ml, 4 hours). (D) Viral titer in the
supernatant collected at 1 d.p.i. and 2 d.p.i. was determined by a plaque assay. (E) At 4 hours post-infection, supernatant was replaced with fresh
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cHV68-infected Mice
Given that CCL5 and CXCL1 represent chemokines important
for immune cell recruitment [27,28], we surmised that the
increased levels of CCL5 and CXCL1 in the lung (Figure 1A)
likely translate into more robust infiltration of immune cells in
Mavs
2/2 mice than in Mavs
+/+ littermates. We examined mouse
lungs from mock- or cHV68-infected (40 PFU, intranasally) mice
by hematoxylin and eosin (H&E) staining. We observed similar
lung architecture and no immune cell infiltration in the lung of
mock-infected Mavs
+/+ and Mavs
2/2 mice (Figures 2A,S4A; top
panels). Compared to mock-infected mice, the lungs of both
Mavs
+/+ and Mavs
2/2 mice at 10 d.p.i. displayed apparent
increase in cellularity (Figures 2A,S4A). In the lung of cHV68-
infected Mavs
+/+ mice, there was an isolated mild mixed-cell
perivascular infiltration of lymphocytes, macrophages, and rare
neutrophils. Strikingly, we observed an intensely increased
cellularity within perivascular and peribrochial regions, caused
by a massive influx of macrophages, neutrophils, and lymphocytes
in the lung of cHV68-infected Mavs
2/2 mice. Evidently, the
immune infiltrated regions extended from blood vessels and
bronchioles into alveolar interstitium. It is important to note that,
at 7 d.p.i., no significant immune cell infiltration was observed in
the lung of either Mavs
+/+ or Mavs
2/2 mice (data not shown),
suggesting that immune cell infiltration is the consequence of the
rising cytokine levels in Mavs
2/2 lungs at 7 d.p.i. Thus, the
expansion of immune infiltrated regions in Mavs
2/2 lungs is likely
the sequela of cHV68 infection and cytokine production thereof.
To further characterize the infiltrated immune cells, pulmonary
macrophages were examined by immunohistochemistry staining
using a specific antibody, anti-Iba1 (Figure S4B). We observed
sporadic and evenly distributed Iba1-positive cells, likely lung-
residential macrophages, in mock-infected mice (Figures 2B,S4C;
top panels). Consistent with H&E staining, there were much more
and larger Iba1-positive foci, in the lung of cHV68-infected
Mavs
2/2 mice than those of Mavs
+/+ littermates (Figures 2B,S4C),
indicative of escalated inflammation in Mavs
2/2 mice. Moreover,
we counted macrophages within eight randomly selected fields,
and found that cHV68 infection increased lung macrophages by
approximately three-fold in Mavs
+/+ mice, whereas by more than
five-fold in Mavs
2/2 mice (Figure 2C). Because of the intense
staining of Iba1-positive macrophages in Mavs
2/2 lungs, the
increase of macrophages caused by cHV68 infection is likely
underestimated.
Neutrophils serve as a hallmark indicator for inflammation and
CXCL1 is a major chemokine for neutrophil recruitment. We
then examined neutrophils in the lungs of cHV68-infected mice by
an esterase specific staining. In contrast to macrophages,
neutrophils were rarely observed in the lung of mock-infected
mice, or those of cHV68-infected Mavs
+/+ mice (Figures 2D,S4D).
However, neutrophils were easily detected within immune
infiltrated regions in the lung of cHV68-infected Mavs
2/2 mice
(Figures 2D,S4D). Counting neutrophils within eight randomly
selected fields revealed that cHV68 infection increased neutrophils
by approximately five-fold in the lung of Mavs
2/2 mice, whereas it
had a negligible effect on neutrophil recruitment in Mavs
+/+ mice
(Figure 2E). Taken together, these results suggest that the elevated
chemokine production promotes the infiltration of immune cells,
including macrophages and neutrophils, into cHV68-infected
lungs. Altogether, we conclude that MAVS is necessary for cHV68
to dampen cytokine production and subsequent inflammatory
responses in the lung.
cHV68 Abrogates Cytokine Production in a MAVS-
dependent Manner
Professional innate immune cells, such as macrophages, are the
major source to produce antiviral cytokines and MAVS is crucial
for cytokine secretion from macrophages induced by intracellular
pathogens [23,24]. To test whether MAVS deficiency increases
cytokine production in cHV68-infected macrophages, we isolated
bone marrow-derived macrophages (BMDMs) and determined
cytokines secreted by BMDMs in response to cHV68 infection. As
expected, loss of MAVS greatly impaired IL6 and CXCL1
secretion in BMDMs infected by Sendai virus (SeV), a prototype
RNA virus (Figure S5). Interestingly, we found that cHV68
infection induced equivalent levels of IL6 and TNFa in Mavs
+/+
and Mavs
2/2 BMDMs, in a dose-dependent manner (Figure 3A).
Moreover, loss of MAVS reduced CXCL1 secretion from cHV68-
infected BMDMs, albeit with boarder-line statistical significance
(Figure 3A). Thus, upon cHV68 infection, MAVS deficiency does
not elevate the intrinsic ability of BMDMs to produce cytokines.
Having excluded that MAVS deficiency elevates the intrinsic
cytokine production by macrophages, we surmised that the
elevated cytokines in cHV68-infected Mavs
2/2 mice, at least
during early infection (e.g., 7 d.p.i.), are likely produced by lung
epithelium/fibroblasts. Next, we tested whether MEFs recapitulate
the MAVS-dependent avoidance of cytokine production and
examined cytokines secreted from cHV68-infected MEFs by
ELISA. cHV68 infection induced significantly more IL6 and
CCL5 in Mavs
2/2 MEFs than Mavs
+/+ MEFs (Figure 3B),
recapitulating the phenotypic cytokine production observed in
cHV68-infected mice (Figure 1A). It is important to note that
MAVS deficiency does not elevate cytokine production in mock-
infected MEFs (Figure 3C). As expected, SeV infection induced
much more IL6 in Mavs
+/+ MEFs than in Mavs
2/2 MEFs,
confirming the MAVS-dependent cytokine production in response
to infection by a prototype RNA virus (Figure 3D). Interestingly,
we found that mRNA and protein levels of cytokines were
inversely correlated with the levels of cHV68 replication in the
lung of BL/6 mice (Figure S6), suggesting that cHV68 inhibits
cytokine production at the transcription level.
MAVS is Necessary for cHV68 Infection to Abrogate NFkB
Activation
Two main signaling cascades, i.e., NFkB and IRF-IFN
pathways, are known to relay MAVS-dependent innate immune
activation (Figure 4A). In response to viral infection, NFkB
activation downstream of MAVS and IKKb is essential for gene
expression and secretion of antiviral cytokines. Therefore, we
assessed the mRNA levels of CCL5, IL6 and TNFa in cHV68-
infected MEFs by quantitative real-time PCR. cHV68 infection
robustly increased the mRNA abundance of all three cytokines
within 6 hours post-infection (h.p.i.) in Mavs
2/2 MEFs, which was
not observed in cHV68-infected Mavs
+/+ MEFs (Figure 4B).
Moreover, loss of MAVS reduced IFN-b gene expression induced
by cHV68 infection (Figure S7), indicating the specificity of
MAVS utilization by cHV68. Finally, cHV68 infection failed to
up-regulate gene expression of these inflammatory cytokines in
DMEM containing 2% FBS and 0.75% methylcellulose. Plaques formed in MEF monolayers were counted at 6 d.p.i. Data in (D) and (E) are presented as
the mean 6 SEM of three independent experiments. The statistical significance in (A), (C), (D) and (E): *, P,0.05; **, P,0.02.
doi:10.1371/journal.ppat.1002336.g001
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PLoS Pathogens | www.plospathogens.org 4 November 2011 | Volume 7 | Issue 11 | e1002336Figure 2. Loss of MAVS increases immune cell infiltration in the lung of cHV68-infected mice. Age- and gender-matched Mavs
+/+ and
Mavs
2/2 l i t t e r m a t em i c ew e r ei n t r a n a s a l l yi n f e c t e dw i t h4 0P F Uo fcHV68 as in Figure 1A. At 10 days post-infection, mouse lungs were fixed and embedded
in paraffin. Three-micrometer paraffin sections of lungs were stained, and pictures were taken at the magnification of 200. One to three optical fields are
presented for each group. See also Figure S4. (A) Hematoxylin and eosin (H&E) staining demonstrated a mild mixed-cell infiltration in the lung of cHV68-
infected Mavs
+/+ mice, and an intense peribronchial and perivascular immune cell infiltration in the lung of cHV68-infected Mavs
2/2 m i c e .A ,a i r w a y ;V ,b l o o d
vessel. (B and C) Pulmonary macrophages (brown) were probed with anti-Iba1 antibody. (D and E) Pulmonary neutrophils (red arrowheads) were selectively
stained by an esterase specific assay. In (C) and (E), the number of pulmonary macrophages (C) or perivascular neutrophils (E) was determined by counting
eight randomly selected optical fields. Data are presented as the mean 6 SEM. The statistical significance: *, P,0.05; **, P,0.02; ***, P,0.005.
doi:10.1371/journal.ppat.1002336.g002
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PLoS Pathogens | www.plospathogens.org 5 November 2011 | Volume 7 | Issue 11 | e1002336Figure 3. MAVS deficiency results in increased cytokine production in cHV68-infected MEFs. Mavs
+/+ and Mavs
2/2 bone marrow-derived
macrophages (BMDMs) were infected with cHV68 at an MOI of 0.2, 1, and 5 for 3 hours (A). Mavs
+/+ and Mavs
2/2 mouse embryonic fibroblasts (MEFs)
were infected with cHV68 at an MOI of 5 (B) or 500 HA units of Sendai virus (SeV) (D), or mock infected (C). Cytokine levels in the supernatant were
determined by ELISA. See also Figure S5. (A) IL6, TNFa, and CXCL1 secreted by cHV68-infected Mavs
+/+ and Mavs
2/2 BMDMs. (B) IL6 and CCL5
secreted by cHV68-infected Mavs
+/+ and Mavs
2/2 MEFs. (C) IL6 and CCL5 secreted by mock-infected Mavs
+/+ and Mavs
2/2 MEFs. (D) IL6 secreted by
SeV-infected Mavs
+/+ and Mavs
2/2 MEFs. Data are presented as the mean 6 SEM of three independent experiments. The statistical significance:
*, P,0.05; **, P,0.02; ***, P,0.005.
doi:10.1371/journal.ppat.1002336.g003
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the notion that activated IKKb is necessary for cytokine
production in response to viral infection. These results suggest
that MAVS is necessary for cHV68 to prevent cytokine gene
expression and that up-regulated gene expression likely underpins
the increased cytokine secretion in Mavs
2/2 MEFs. Thus, we
examined NFkB activation by electrophoresis mobility shift assay
(EMSA). Agreeing with the elevated cytokine gene expression in
Mavs
2/2 MEFs, cHV68 infection imparted more robust DNA-
binding activity of NFkB in nuclear extract of Mavs
2/2 MEFs
than that of Mavs
+/+ MEFs (Figure 4C). The specificity of EMSA
for NFkB was confirmed by a competition assay using a cold probe
and a super-shift assay using a RelA-specific antibody (Figure S9).
Densitometry analysis further showed that the DNA-binding
activity of NFkB, induced by cHV68 infection, in Mavs
2/2 MEFs
was approximately two-fold of that in Mavs
+/+ MEFs (Figure 4C).
RelA phosphorylation at serine 536 (Ser536) was demonstrated as
a marker for NFkB activation [29]. We further examined the
Ser536 phosphorylated RelA by immunoblot and found that
cHV68 infection also triggered a robust accumulation of the
Ser536 phosphorylated RelA in Mavs
2/2 MEFs, but not in Mavs
+/+
MEFs (Figure 4D). To confirm that loss of MAVS is responsible for
increased cytokine production induced by cHV68, we ‘‘reconsti-
tuted’’ MAVS expression by lentivirus in Mavs
2/2 MEFs
(Figure 4E), and examined gene expression of cytokines (such as
TNFa and CCL5) in response to viral infection. We found that the
‘‘reconstituted’’ expression of MAVS reduced cytokine gene
expression triggered by cHV68 (Figure 4F), whereas up-regulated
cytokine gene expression induced by VSV and SeV (Figure 4G),
supporting the premise that loss of MAVS elevated cHV68-induced
cytokine production. Collectively, these results indicate that MAVS
is critical for cHV68 to negate NFkB activation and cytokine gene
transcription in cHV68-infected cells.
cHV68 Induces RelA Degradation in an MAVS- and IKKb-
dependent Manner
To dissect the molecular mechanism by which cHV68
uncouples NFkB activation from IKKb activation, we examined
RelA protein in cHV68-infected MEFs by immunoblot analysis.
RelA is the most ubiquitously and abundantly expressed subunit of
the transcriptionally active NFkB dimer. We found that cHV68
infection abolished RelA protein at 4 h.p.i. Moreover, treatment
by the proteasome inhibitor MG132, but not by the lysosome
inhibitor chloroquine, completely restored RelA protein
(Figure 5A). These results indicate that cHV68 infection induces
the proteasome-dependent degradation of RelA.
We noted that cHV68 infection also induced the degradation of
the inhibitor of NFkB( I kBa), which serves as an indicator of
IKKb activation (Figure 5A). To test whether IkBa degradation is
necessary for cHV68-induced RelA degradation, we established
Mavs
+/+ MEFs stably expressing the IkBa super-suppressor,
IkBaDN, by lentivirus infection and confirmed IkBaDN expres-
sion by immunoblot (Figure 5B). Notably, the IkBaDN expression
decreased the steady state level of RelA and we analyzed RelA
protein in these two MEF cell lines separately. Surprisingly, in
MEFs expressing the IkBaDN, RelA protein gradually disap-
peared, albeit in a slower kinetics, with the progression of cHV68
infection (Figure 5C), indicating that IkBa degradation is
dispensable for RelA degradation in cHV68-infected MEFs. As
expected, IkBaDN was not degraded in cHV68-infected MEFs,
and IkBaDN potently abrogated RelA nuclear translocation that
was induced by TNFa treatment (Figure S10). RelA degradation
was not observed after infection by VSV and SeV, nor after
treatment with lipopolysaccharide (Figure 5D). Next, cHV68-
induced RelA degradation was further examined by immunoflu-
orescence microscopy after treatment with MG132. Consistent
with the proteasome-mediated RelA degradation, MG132 treat-
ment restored RelA protein in cHV68-infected MEFs, with
significant accumulation in the cytosol (Figure 5E). Collectively,
these findings support the conclusion that cHV68 induces RelA
degradation in an IkBa-independent manner.
NFkB activation and cytokine gene expression induced by
cHV68 appear to be transient in Mavs
2/2 MEFs, implying the
dynamic regulation of the NFkB pathway by cHV68 infection.
We assessed the kinetics of RelA protein in wild-type, Mavs
2/2,
Ikkb
2/2, and Ikkc
2/2 MEFs infected with cHV68. Within 4 h.p.i.,
RelA protein gradually diminished in wild-type MEFs (Figure 6A).
Remarkably, RelA protein re-appeared at 8 h.p.i. in wild-type
MEFs, suggesting a transient RelA degradation triggered by
cHV68 infection. However, relatively equivalent RelA protein was
maintained in Mavs
2/2, Ikkb
2/2, and Ikkc
2/2 MEFs with the
progression of cHV68 infection (Figure 6A). It is noteworthy that
cHV68-induced RelA degradation in Ikka
2/2 MEFs was
comparable to that in Mavs
+/+ MEFs (Figure S11), implying that
IKKa is dispensable for RelA degradation induced by cHV68.
These results imply that the integral MAVS-IKKb signaling node
is important for cHV68 to induce transient RelA degradation.
When exogenous MAVS and IKKb were re-introduced by
lentivirus infection, cHV68 infection induced a transient RelA
degradation (Figures 6B,6C), bolstering the specific requirement
for MAVS and IKKb in RelA degradation triggered by cHV68
infection. To determine whether elevated IKKb is sufficient for
RelA degradation induced by cHV68 infection, we expressed
exogenous IKKb with lentivirus in Mavs
2/2 MEFs and found that
cHV68 infection failed to reduce RelA protein (Figure 6D). Thus,
this result supports the conclusion that the MAVS-dependent
IKKb activation, rather than the absolute IKKb level, is necessary
for cHV68-induced RelA degradation.
To further characterize the cHV68-induced RelA degradation,
we determined the half-life of RelA in cHV68-infected MEFs in
the presence of cyclohexamide (CHX), an inhibitor of protein
translation. For this experiment, MEFs were infected with cHV68
for 30 minutes and CHX was added to halt protein synthesis. In
cHV68-infected Mavs
+/+ MEFs, the half-life of RelA was reduced
to approximately 2 hours (Figure 6E). CHX treatment, up to
4 hours, did not significantly alter RelA protein level in mock-
infected MEFs. Furthermore, RelA protein remained relatively
constant in cHV68-infected MEFs deficient in MAVS, IKKb,o r
IKKc (Figure 6E). Taken together, these results indicate that
MAVS and IKKb are necessary for cHV68 to induce rapid RelA
degradation. Based on these findings, we conclude that cHV68
induces RelA degradation in a MAVS- and IKKb-dependent, and
IkBa-independent manner.
cHV68 Usurps MAVS and IKKb to Induce the Site-specific
(Serine 468) Phosphorylation of RelA
The MAVS- and IKKb-dependent, IkBa-independent RelA
degradation triggered by cHV68 infection prompted us to
hypothesize that IKKa directly phosphorylates RelA to facilitate
its turnover. Although IKKb is historically known for IkBa
phosphorylation and subsequent degradation, recent studies also
implicated IKKb and IKKa in phosphorylating RelA and
terminating NFkB activation. Two predominant IKKb-mediated
phosphorylation sites, i.e., Serine 536 (Ser536) and Serine 468
(Ser468), have been implicated in regulating RelA turnover
[29,30,31,32,33]. Because we observed significant reduction of
RelA protein levels at 2 h.p.i. (Figures 6A), we reasoned that RelA
phosphorylation by IKKb precedes its degradation and focused on
Viral Hijacking of Host Innate Signal Transduction
PLoS Pathogens | www.plospathogens.org 7 November 2011 | Volume 7 | Issue 11 | e1002336Figure 4. cHV68 abrogates NFkB activation in a MAVS-dependent manner. Mavs
+/+ and Mavs
2/2 mouse embryonic fibroblasts (MEFs) were
infected with cHV68 (MOI=5) (B, C, D, and F), vesicular stomatitis virus (VSV, MOI=10) (G), or Sendai virus (SeV, 1000 HA units) (G). See also Figure S6.
(A) Two main signaling pathways downstream of the MAVS adaptor. (B) Relative quantity of cytokine mRNAs in cHV68-infected MEFs. Cytokine mRNA
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PLoS Pathogens | www.plospathogens.org 8 November 2011 | Volume 7 | Issue 11 | e1002336the first hour post cHV68 infection. To further characterize the
activation of the IKKb-NFkB ramification downstream of MAVS,
we have examined TRAF6 translocation and kinase activity of
IKKb after cHV68 infection. We first determined the migration of
TRAF6 into the Triton X-100-insoluable fraction that marks
TRAF6 activation. Indeed, TRAF6 was detected at 30 and 60
minutes post-infection in the Triton X-100 insoluble pellet of
cHV68-infected MEFs, but not in that of mock-infected MEFs
(Figure 6A). We further assessed IKKb activation by cHV68
infection with an in vitro kinase assay. Strikingly, cHV68 infection
potently up-regulated IKKb kinase activity, as demonstrated to
phosphorylate the IkBa N-terminal sequence in vitro, as early as
15 min post-infection (Figure 7B). These results indicate that
cHV68 infection sufficiently instigates the activation of the
MAVS-IKKb pathway.
Next, we examined the RelA phosphorylation at two IKKb
phosphorylation sites, i.e., Ser468 and Ser536, in cHV68-infected
MEFs. We found an accumulation of the Ser536 phosphorylated
RelA in cHV68-infected Mavs
2/2 MEFs, but not in Mavs
+/+
MEFs (Figure 4D), which was consistent with more robust NFkB
activation in Mavs
2/2 MEFs than those in Mavs
+/+ MEFs
(Figure 4C). These results suggest that Ser536-phosphorylated
(Ser536p) RelA represents the activated RelA, and is selectively
being targeted for degradation. We therefore infected MEFs with
cHV68 and treated with MG132 to inhibit protein degradation.
After treatment for 1 hour, the Ser536 phosphorylated RelA was
increased by more than 8-fold, whereas total RelA was only
increased approximately 2-fold (Figure 7C). This result indicates
that activated RelA is being selectively degraded by cHV68
infection. Consistent with the pivotal role of the Ser468
phosphorylated form in promoting RelA degradation, we found
that the Ser468p RelA gradually increased in Mavs
+/+ MEFs, and
conversely decreased in Mavs
2/2 MEFs, infected with cHV68
(Figure 7D). The Ser468p RelA, under both basal and cHV68-
infected conditions, was not observed in Ikkb
2/2 MEFs and
severely impaired in Ikkc
2/2 MEFs (Figure 7D), indicating that
activated IKKb is necessary for RelA phosphorylation at Ser468.
The distinct pattern of RelA phosphorylation in cHV68-infected
MEFs, dependent on MAVS expression (Figures 4D,7D), suggests
the site-specificity of RelA phosphorylation instigated by cHV68.
These results also agree with the requirement of IKKb activation
for RelA degradation triggered by cHV68 (Figure 6), linking RelA
Ser468 phosphorylation to its degradation.
The MAVS-dependent RelA Phosphorylation at Ser468 is
Necessary for cHV68-induced RelA Degradation
RelA phosphorylation at Ser468 represents a key step in
promoting RelA ubiquitination, we then assessed the ubiquitina-
tion of RelA by immuno-precipitation with anti-RelA antibody
and immunoblot with anti-ubiquitin antibody. When treated with
MG132 for two hours, cHV68-infected Mavs
+/+ MEFs accumu-
lated detectable levels of high molecular species shown by the
smearing of RelA, indicative of RelA ubiquitination (Figure 8A).
By contrast, the smeared RelA proteins were not observed in
cHV68-infected Mavs
2/2 MEFs (Figure 8A). In the absence of
MG132, ubiquitinated RelA was not detected in both Mavs
+/+ and
Mavs
2/2 MEFs with or without cHV68 infection. The fact that
RelA ubiquitination was only detected with MG132 treatment in
cHV68-infected Mavs
+/+ MEFs implies that RelA ubiquitination is
the rate-limiting step in the process of degrading RelA.
To determine whether the Ser468 phosphorylation of RelA is
necessary for its degradation, we established Mavs
+/+ MEFs that
stably express the RelA variant carrying the Serine 468-to-Alanine
mutation (RelA.S468A) or wild-type RelA by lentivirus infection,
and assessed RelA ubiquitination in cHV68-infected MEFs. We
found that the exogenously expressed wild-type RelA was
efficiently ubiquitinated, and that the S468A mutation abrogated
the ubiquitination of the RelA.S468A variant in cHV68-infected
Mavs
+/+ MEFs, supporting the proposition that the Ser468
phosphorylation is necessary for efficient RelA ubiquitination
(Figure 8B). When cHV68-infected Mavs
+/+ MEFs were treated
with MG132, the ubiquitinated RelA.S468A was observed at a
lower level than the ubiquitinated wild-type RelA (Figure 8B).
Next, the effect of the RelA.S468A variant on cHV68-induced
RelA degradation was assessed. The exogenous RelA.S468A
variant, although expressed at a lower level than wild-type RelA,
was resistant to degradation induced by cHV68 infection, but
wild-type RelA was not (Figure 8C). Interestingly, the exogenously
expressed RelA.S468A variant also protected endogenous RelA
from cHV68-induced degradation (Figure 8C), suggesting that the
RelA.S468A variant functions as a dominant negative of RelA
degradation.
To evaluate the contribution of transient RelA degradation to
the reduced cytokine production, we determined whether the
expression of the RelA.S468A variant, which inhibited RelA
degradation, is sufficient to up-regulate cytokine gene expression
in response to cHV68 infection. We used quantitative real-time
PCR analysis to examine the mRNA levels of IL6, CCL5 and
TNFa. We have noticed that the expression of the RelA.S468A
variant had a marginal effect on the basal level of mRNAs of IL6
and CCL5, whereas the RelA.S468A expression elevated basal
TNFa mRNA over 1,000 fold (Figure 8D). Regardless of the basal
mRNA levels, the expression of the RelA.S468A variant greatly
increased IL6 and CCL5 mRNA levels induced by cHV68
infection (Figure 8D). Although the basal TNFa mRNA was
exceedingly high in MEFs expressing the RelA.S468A variant,
cHV68 infection further increased TNFa mRNA to approxi-
mately 2,500 fold (Figure 8D). Consistent with the up-regulation of
cytokine gene expression, the RelA.S468A variant also increased
IL6 and CCL5 secretion in cHV68-infected MEFs (Figure 8E).
Notably, despite that TNFa mRNA was highly up-regulated by
RelA.S468A and cHV68 infection, TNFa secretion was under
detection in MEFs (data not shown). Finally, the exogenous
expression of the RelA.S468A variant reduced cHV68 lytic
replication under both permissive and restricted (methylcellulose-
containing) conditions (Figure S12). These results suggest that
inhibiting RelA degradation is sufficient to restore cytokine gene
expression and production in cHV68-infected Mavs
+/+ MEFs, and
levels were analyzed by real-time PCR and normalized to that of b-actin. See also Figure S7 and Figure S8. (C) Nuclear fractions (2 mg) were prepared
from cHV68-infected or TNFa-treated MEFs and analyzed by electrophoresis mobility shift assay (EMSA) (left). The NFkB bands (black arrow) were
quantified by densitometry and normalized to that of the mock-infected Mavs
+/+ MEFs (right). See also Figure S9. (D) Whole cell lysates (WCLs) of
cHV68-infected Mavs
+/+ and Mavs
2/2 MEFs were analyzed by immunoblot with antibodies specific for the Ser536 phosphorylated (Ser536p) RelA,
total RelA, and b-actin. (E to G) MAVS expression was ‘‘reconstituted’’ by lentivirus as described in Materials and Methods. (E) MAVS expression was
confirmed by immunoblot with anti-Flag antibody. (F and G) Relative quantity of cytokine mRNAs in control (Mavs
2/2.Vec) or MAVS-reconstituted
(Mavs
2/2.MAVS) MEFs infected with cHV68 (F), VSV (G) or SeV (G) were analyzed by real-time PCR as in (B). Data are presented as the mean 6 SEM of
three independent experiments. The statistical significance: *, P,0.05; **, P,0.02.
doi:10.1371/journal.ppat.1002336.g004
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PLoS Pathogens | www.plospathogens.org 9 November 2011 | Volume 7 | Issue 11 | e1002336Figure 5. cHV68 infection induces RelA degradation in an IkBa-independent manner. Mouse embryonic fibroblasts (MEFs) were infected
with cHV68 K3/GFP at an MOI of 20 (A, C, and E), or vesicular stomatitis virus (VSV, MOI=10) (D), or Sendai virus (SeV, 4000 HA units) (D), or treated
with lipopolysaccharides (LPS, 200 mg/ml). (A) Protein levels of RelA, IkBa, and b-actin in whole cell lysates (WCLs) from cHV68-infected wild-type
MEFs at 4 h.p.i. were analyzed by immunoblot. MG, MG132 (20 mM); Ch, chloroquine (50 mM). (B and C) Wild-type MEFs stably expressing the Flag-
tagged IkBa super-suppressor (IkBaDN) were established as described in Materials and Methods. The expression of endogenous and exogenous IkBa
was examined by immunoblot (B). WCLs of cHV68-infected control (Vector) or IkBaDN-expressing MEFs were separately analyzed by immunoblot
with indicated antibodies (C), to facilitate the detection of RelA that was reduced by IkBaDN expression. Relative quantity of RelA in cHV68-infected
MEFs was normalized to b-actin (right). See also Figure S10. (D) Wild-type MEFs were infected with VSV, SeV, or treated with LPS, and WCLs were
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PLoS Pathogens | www.plospathogens.org 10 November 2011 | Volume 7 | Issue 11 | e1002336demonstrate a requisite role of the Ser468 phosphorylation in
efficient RelA ubiquitination and degradation induced by cHV68.
Our findings uncover an essential role of MAVS in specifying the
site-specific (Ser468) phosphorylation of RelA to promote RelA
degradation and terminate NFkB activation, thereby effectively
preventing cytokine production induced by cHV68 infection.
Discussion
Recent studies have demonstrated that, in response to viral
infection, the MAVS adaptor protein relays innate immune
signaling from cytosolic sensors to NFkB and IRF activation that
up-regulate antiviral cytokine production. Mice deficient in
MAVS are severely compromised in host defense against infection
of several viruses [23,24,34]. Moreover, viruses of the positive-
stranded RNA family target MAVS for destruction to disable host
innate immune responses [9,35,36,37,38]. In this study, we report
that cHV68 hijacks MAVS and its immediately downstream
IKKb kinase to degrade RelA, a key subunit of the transcription-
ally active NFkB dimer. In doing so, cHV68 effectively terminates
NFkB activation and negates cytokine production. To our
knowledge, this is the first example whereby signaling via the
upstream components of the innate immune pathways, MAVS
and IKKb, is intercepted by a pathogen to degrade the critical
downstream effector, RelA, a master transcription factor that
governs the expression of a myriad of genes of immune function.
Given the common biological properties shared by members of the
gamma herpesvirus family, it is possible that human KSHV and
EBV have evolved equivalent tactics to evade cytokine production.
An Intricate Immune Evasion Strategy: Hijacking Innate
Immune Signaling Activation to Abrogate Cytokine
Production
Our observation that the MAVS-IKKb pathway, which
otherwise activates NFkB and promotes cytokine production, is
directed by cHV68 to assist in degrading RelA and terminating
NFkB activation is surprising. Moreover, cHV68 infection
resulted in elevated cytokines in mice and fibroblasts that are
deficient in MAVS, indicating that MAVS is an integral player of
the active evasion scheme to abrogate host cytokine production.
The elevated cytokine production in MAVS-deficient mice and
MEFs, in response to cHV68 infection, is opposite to what was
observed for RNA virus infection [23,24]. Our study thus
highlights an unrecognized role of MAVS and IKKb in
terminating NFkB activation. These findings also explain an early
report that IL6 deficiency had no apparent effect on cHV68
infection [26], in that cHV68 effectively negates cytokine (such as
IL6) production during early viral infection. Presumably, the
ability of cHV68 to abolish cytokine production contributes to the
minimal, if any, effect of IL6 deficiency on cHV68 lytic
replication, and implies that physiological function of cytokines
against cHV68 may be better defined in mouse strains (e.g.,
Mavs
2/2 mouse) that cHV68 infection induces more antiviral
cytokines. Alternatively, exogenous cytokines may be delivered to
cHV68-infected mice during early infection when cytokines are
not produced. Indeed, we showed that treatment with IL6 and
TNFa greatly reduced cHV68 replication in vivo and ex vivo,
demonstrating their antiviral activity against cHV68 lytic
replication.
The significance of elevated inflammatory cytokines, which
were approximately two-fold of those in Mavs
+/+ mice, is
substantiated by escalated immune cell infiltration in the lung of
Mavs
2/2 mice. Evidently, cHV68 infection resulted in significant-
ly more infiltrated immune cells in the lung of Mavs
2/2 mice than
those of Mavs
+/+ mice. It is important to point out that West Nile
virus was recently reported to induce an uncontrolled inflamma-
tory response in Mavs
2/2 mice, including a signature of higher
serum levels of multiple inflammatory cytokines [34]. The elevated
cytokine production likely stems from an increased viral load, and
is further compounded by the lack of negative feedback
mechanisms on host immune responses. By contrast, cHV68
replicated to relatively equivalent (7 d.p.i.) or lower (10 d.p.i.) viral
loads in Mavs
2/2 mice than in Mavs
+/+ mice. This observation
excludes the contribution of higher viral loads in Mavs
2/2 mice to
the elevated cytokine production and further emphasizes the roles
of MAVS in evading cytokine production by cHV68. Conceiv-
ably, loss of MAVS in lung fibroblasts/endothelial cells, which
support cHV68 lytic replication, increases the cytokine production
during early cHV68 infection (e.g., 7 d.p.i.). One notable common
property of lung fibroblasts and embryonic fibroblasts is the
abundant expression of the innate immune signaling components,
providing a physiological rationale to dissect signal transduction in
cHV68-infected MEFs. In fact, we recapitulated the MAVS-
dependent reduction in cytokine secretion using cHV68-infected
MEFs. By contrast, bone marrow-derived macrophages of Mavs
2/2
mice secreted either similar or lower levels of cytokines than those of
Mavs
+/+ mice in response to cHV68 infection. Based on these
observations, we propose that cHV68-induced cytokines in the lung
are produced in a biphasic process: the initial low-level production
by lung fibroblasts and more robust production by infiltrated
immune cells during late stages of cHV68 infection. Within this
scenario, cytokines of the initial phase recruit and stimulate the
proliferation of immune cells (e.g., macrophages and neutrophils)
that release more cytokines during late infection, such as at 13 and
16 d.p.i., when replicating cHV68 was cleared. These results
collectively indicate that loss of MAVS elevates host innate immune
responses against cHV68 and support the conclusion that elevated
immune responses, in turn, negatively impact the lytic replication of
cHV68 in Mavs
2/2 mice.
Manipulating the host immune response has been a recurring
theme for host-pathogen interactions [39,40]. As intracellular
pathogens, viruses are obligate to utilize host components to
achieve efficient replication and dissemination. Host innate
immunity is the first line of defense that plays critical roles in
containing invading viruses during early viral infection. We have
witnessed a growing list of strategies by which pathogens deploy to
evade host innate immune responses [41,42,43,44]. Many of
which are evolved to thwart cytokine production or signal
transduction thereof, such as IFNs. Although negating NFkB
activation by pathogens has been reported previously, our study
showing that MAVS and IKKb are hijacked to promote RelA
phosphorylation and degradation unravels an active evasion
strategy whereby activation of upstream signaling events are
exploited to nullify the immediate downstream event. Given the
fundamental functions of innate immune signaling pathways in
cellular physiology, the discovery that pathogens exploit these
signaling events for their own benefit is not a complete surprise
and emerging studies support this evolving theme [45,46,47].
analyzed by immunoblot with indicated antibodies. (E) MG132 treatment induced RelA accumulation in the cytosol of cHV68-infected MEFs. Wild-
type MEFs were treated with TNFa (10 ng/ml, 30 min) (left) or infected with cHV68 without or with MG132 (20 mM) for 2 hours (right). A
representative optical field is presented for each group. Data represent three independent experiments.
doi:10.1371/journal.ppat.1002336.g005
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PLoS Pathogens | www.plospathogens.org 11 November 2011 | Volume 7 | Issue 11 | e1002336Figure 6. cHV68 infection induces transient RelA degradation in a MAVS- and IKKb-dependent manner. Mouse embryonic fibroblasts
(MEFs) of indicated genotypes were infected with cHV68 K3/GFP at an MOI of 20. Whole cell lysates (WCLs) were analyzed by immunoblot. (A) cHV68-
infected MEFs were collected at various time points. RelA levels in WCLs were analyzed by immunoblot. See also Figure S11. (B and C) MAVS and IKKb
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One of the well-defined mechanisms that regulate NFkB
activation is the phosphorylation and degradation of IkBs. For
example, activated IKKb phosphorylates IkBa to induce its
degradation, unleashing NFkB that promotes the transcription of
various genes, including IkBa. cHV68 infection appears to
activate IKKb that, in turn, triggers the degradation of both
IkBa and RelA. Intriguingly, these two seemingly coupled
processes are independent from each other and IkBa degradation
is dispensable for RelA degradation in cHV68-infected cells.
Evidently, cHV68 infection effectively uncouples NFkB activation
from IKKb activation by inducing RelA degradation in an IkBa-
independent manner. Krug et al. previously reported that the
expression of the IkBa super-suppressor had no apparent effect on
cHV68 lytic replication [48], whereas RelA was found to inhibit
cHV68 lytic replication [25]. Thus, the IkBa-independent
degradation of RelA, triggered by cHV68, offers a plausible
interpretation for the apparent paradoxical effect of RelA and the
IkBa super-suppressor on cHV68 lytic replication. Finally, data
from our studies employing the IkBaDN super-suppressor and
MG132 treatment imply that cHV68 induces RelA degradation in
the cytosol, although further investigation is necessary to address
this possibility. Altogether, these studies are en route to assemble
an overall picture regarding the dynamic regulation of NFkB-
dependent gene transcription in cHV68 lytic replication.
Besides IkBs, IKKb differentially regulates NFkB activation via
phosphorylation of two serine residues within the carboxyl
terminal region of RelA, i.e., Ser468 and Ser536. Whereas the
Ser536 phosphorylation of RelA potentiates NFkB-dependent
gene transcription through recruiting p300 [49], the Ser468
phosphorylation instigates RelA degradation [31,32,33]. It is
noteworthy that RelA phosphorylation at Ser536 by IKKa was
reported to facilitate RelA degradation in macrophages [30]. In
this study, we found that cHV68 infection induced a gradual
increase of the Ser468p RelA in Mavs
+/+ MEFs, whereas a gradual
decrease of the Ser468p RelA was observed in cHV68-infected
Mavs
2/2 MEFs. Importantly, the phosphorylated forms of RelA,
e.g., Ser468p and Ser536p, account only a minor fraction of the
total pool of RelA and that the bulky part of RelA remains
constant. In fact, RelA depletion by cHV68 infection requires a
high MOI (MOI=20), although NFkB termination necessitates a
relatively lower MOI (MOI=5). The increase of the Ser468p
RelA correlated with more efficient ubiquitination and rapid
degradation of RelA in cHV68-infected Mavs
+/+ MEFs. Con-
versely, the increase of the Ser536p RelA correlated with NFkB
activation and the up-regulated gene expression of inflammatory
cytokines in cHV68-infected Mavs
2/2 MEFs. The key roles of the
S468 phosphorylation of RelA is further substantiated by the
observations that the expression of the RelA.S468A variant
sufficiently inhibited cHV68-induced RelA degradation and
restored cytokine gene expression. Collectively, these results
support the corollary that cHV68 usurps MAVS to facilitate
RelA phosphorylation at Ser468, which primes RelA for the
proteasome-mediated degradation in Mavs
+/+ MEFs. We observed
that MG132 treatment greatly increased the Ser536p RelA, but
exhibited much less effect on total RelA protein, favoring the
possibility that the Ser536p RelA may be specifically targeted for
Ser468 phosphorylation in cHV68-infected Mavs
+/+ MEFs.
Nevertheless, our findings highlight a critical role of MAVS in
the site-specific phosphorylation (Ser468) of RelA to promote
RelA degradation and terminate NFkB-dependent gene transcrip-
tion.
In response to cHV68 infection, the NFkB activation and
cytokine gene expression in Mavs
2/2 MEFs is transient, suggesting
that cHV68 may exploit additional unknown signaling pathways
to evade NFkB-mediated cytokine production. One candidate is
the MyD88-dependent pathway, which is supported by a recent
study showing that KSHV utilizes TLR7 to promote viral
reactivation from latency. Mouse and MEFs deficient in MAVS
and/or MyD88 will enable the interrogation of these two key
adaptor molecules in cHV68 infection. A closely-related and
logical extension of the above question is how cHV68 is sensed to
promote NFkB activation and cytokine production in MAVS-
deficient mouse and MEFs. Although MAVS is dispensable, IKKb
is absolutely required for cHV68-induced NFkB activation and
cytokine production, consistent with the notion that IKKb is a
major antiviral innate immune kinase responsible for NFkB
activation. Additional experiments are under way to identify
potential pathways that induce NFkB activation in a MAVS-
independent manner.
Viral Manipulation of the NFkB Pathway
Although IKKa and IKKb are primarily responsible for NFkB
activation downstream of a broad spectrum of physiological
stimuli, IKK kinases are equally essential for NFkB termination.
Through the exact same kinases, the opposing outcomes of NFkB
transcription factors are likely engendered by distinct upstream
signaling cascades. Therefore, biochemical studies characterizing
these signaling events that differentially provoke either NFkB
activation or NFkB termination will reveal insight into the
mechanisms governing NFkB-mediated transcription. Such mech-
anisms are expected to dictate the amplitude and duration of
inflammatory immune responses. It is very likely that host-virus
interactions upstream of MAVS, when coupled with a downstream
viral effector(s), efficiently induce RelA degradation. Several E3
ligases have been reported to promote RelA degradation under
various conditions [32,50,51,52], however, the cellular E3 ligases
that are responsible for IKKa-dependent RelA degradation in
macrophage remain unknown. Regardless of the nature of the
cellular E3 ligases involved in cHV68-induced RelA degradation,
it will be informative to identify the viral factor(s) that couples
RelA degradation to the activation of the MAVS-IKKb pathway
during early cHV68 infection. The fact that cyclohexamide
treatment, at 30 min post-infection, did not abolish cHV68-
induced RelA degradation implies that a structural component(s)
of the incoming virion is capable of accelerating RelA turnover.
However, we can not exclude the immediately early viral gene
products that are likely expressed within 30 min post-infection
when cells are infected at an MOI of 20. Recently, the latent
nuclear antigen LANA of cHV68 and RTA of KSHV were
reported to degrade RelA and IRF3/7, respectively [53,54].
Experiments are under way to identify viral factors (including
LANA and RTA) that induce RelA degradation. Together,
information obtained from these studies will provide an overview
expression was ‘‘reconstituted’’ by lentivirus as described in Materials and Methods. MAVS or IKKb expression was confirmed by immunoblot
(right). Viral infection and immunoblot analyses for RelA proteins were carried out as in (A). (D) Exogenous IKKb was expressed by lentivirus. WCLs of
Mavs
2/2.Vec or Mavs
2/2.IKKb infected with cHV68 were analyzed by immunoblot with antibodies to RelA and b-actin. (E) MEFs were mock-infected
or infected with cHV68 for 30 min, and treated with cycloheximide (CHX, 20 mg/ml). WCLs were analyzed by immunoblot for RelA and b-actin.
Relative quantity of RelA in cHV68-infected MEFs was normalized to b-actin (right). Data represent three independent experiments.
doi:10.1371/journal.ppat.1002336.g006
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cHV68 infection, guiding us to design better studies on human
KSHV and EBV.
It is important to point out that the innate immune activation
and NFkB manipulation by cHV68 occur immediately after viral
infection, temporal period that we know very little. Conceivably,
Figure 7. MAVS and IKKb are important for cHV68-induced RelA phosphorylation at serine 468. Mouse embryonic fibroblasts (MEFs) of
indicated genotypes were infected with cHV68 K3/GFP at an MOI of 20. (A) Mavs
+/+ MEFs were harvested at indicated time points and 20 mg of Triton
X-100-insoluble fractions were analyzed by immunoblot with antibodies to TRAF6 and b-actin. (B) IKKb was precipitated from cHV68-infected Mavs
+/+
MEFs for an in vitro kinase assay. Phosphorylation of the IkBa N-terminus (IkBaNT) was analyzed by autoradiography. Relative intensity of
phosphorylated IkBaNT was normalized to IKKb protein (right). (C) Mavs
+/+ MEFs were infected with cHV68 for 30 min, treated with MG132 (20 mM)
for indicated time. Whole cell lysates (WCLs) were analyzed by immunoblot with indicated antibodies. Total RelA and Ser536 phosphorylated RelA
(RelA.Ser536p) were determined by densitometry analysis and normalized to b-actin (right). (D) WCLs of cHV68-infected MEFs were analyzed by
immunoblot with antibodies specific for Ser468 phosphorylated (Ser468p) RelA, or total RelA, and b-actin. Data represent three independent
experiments.
doi:10.1371/journal.ppat.1002336.g007
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PLoS Pathogens | www.plospathogens.org 14 November 2011 | Volume 7 | Issue 11 | e1002336Figure 8. RelA phosphorylation at Serine 468 is critical for cHV68-induced RelA degradation. Mouse embryonic fibroblasts (MEFs) were
infected with cHV68 K3/GFP at an MOI of 20 (A, B, and C) or 5 (D and E). (A) At 2 hours post-infection, mock- or cHV68-infected Mavs
+/+ and Mavs
2/2
MEFs were treated with MG132 (20 mM) for an hour or left un-treated. Endogenous RelA was precipitated and analyzed by immunoblot with
indicated antibodies. (B) Mavs
+/+ MEFs stably expressing Flag-tagged wild-type RelA (RelA.WT) or the RelA.S468A variant were established as
described in Materials and Methods. MEFs were infected with cHV68 and treated with MG132 (20 mM) as in (A). Exogenous RelA was precipitated with
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determined within the very early phase immediately after viral
infection. Indeed, cHV68 potently activated IKKb within 15 to 30
minutes post-infection, which correlated with the Ser468 phos-
phorylation of RelA. Presumably, the activation kinetics of the
MAVS-IKKb pathway depends on the multiplicity of infection per
cell, and higher doses of infectious cHV68 favor earlier and more
robust activation of IKKb and termination of NFkB.
We have previously demonstrated that cHV68 hijacks the
MAVS-IKKb pathway to promote viral transcriptional activation
via RTA phosphorylation by IKKb [22]. We report here that
cHV68 exploits MAVS and IKKb to promote RelA degradation
and NFkB termination, thereby preventing antiviral cytokine
production. Collectively, our findings argue for the corollary that
cHV68 has evolved a ‘‘one stone, two birds’’ strategy to harness
host innate immune activation through coupling viral transcription
activation and cellular NFkB termination to the MAVS-IKKb
pathway, thereby enabling viral lytic replication while disabling
host cytokine production (Figure 9). It is possible that RelA
degradation and RTA-dependent transcriptional activation are
inherently coupled to promote cHV68 lytic replication. As such,
cHV68 replicates more efficiently in Mavs
+/+ mice than in Mavs
2/2
mice. However, it should be noted that MAVS is critical for
antiviral cytokine production as demonstrated by previous studies
using RNA viruses and this study with isolated macrophages.
Thus, the phenotypes of cHV68 infection in vivo and ex vivo likely
represent ‘‘neutralized’’ outcome of the anti- and pro-viral
activities of MAVS in cHV68 infection. Regardless, our studies
uncover intricate viral exploitation mechanisms of host innate
immune signal transduction.
Materials and Methods
Ethics Statement
All animal work was performed under strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. The
protocol was approved by the Institutional Animal Care and Use
anti-Flag antibody and analyzed by immunoblot with indicated antibodies. (C) Whole cell lysates (WCLs) from cHV68-infected Mavs
+/+ MEFs stably
expressing wild-type RelA or the RelA.S468A variant were analyzed by immunoblot. Endo., endogenous RelA; Exo., exogenous RelA. Relative quantity
of RelA was normalized to b-actin. Percentage of RelA protein was calculated in reference to that of uninfected MEFs (RelA) (right). (D and E) Control
(Vector) or RelA.S468A-expressing Mavs
+/+ MEFs were infected with cHV68 for indicated time. (D) Cytokine mRNA levels were analyzed by real-time
PCR and normalized to that of b-actin. (E) Cytokine levels in the supernatant were determined by ELISA. Data are presented as the mean 6 SEM of
three independent experiments. The statistical significance: *, P,0.05; **, P,0.02; ***, P,0.005. See also Figure S12.
doi:10.1371/journal.ppat.1002336.g008
Figure 9. Dual roles of MAVS and IKKb in cHV68 lytic replication. cHV68 infection activates MAVS and IKKb. Activated IKKb phosphorylates
viral RTA to promote transcriptional activation (right), and cellular RelA to abrogate NFkB activation (left). In doing so, cHV68 infection effectively
couples viral transcriptional activation to innate immune activation, whereas it uncouples NFkB activation from immediately upstream innate signal
transduction to negate antiviral cytokine production. The sum of both culminates in enhancing cHV68 lytic replication. Question marks indicate
unknown viral factors involved in innate immune activation and RelA degradation.
doi:10.1371/journal.ppat.1002336.g009
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Medical Center (permit number: A3472-01).
Cell Lines and Viruses
NIH 3T3 cells, 293T cells, and mouse embryonic fibroblasts
(MEFs) were maintained in DMEM (Mediatech) containing 8%
newborn calf serum (NCS) or fetal bovine serum (FBS), respectively.
Wild-type, Mavs
2/2, Ikka
2/2, Ikkb
2/2,a n dIkkc
2/2 MEFs were
described previously [22,23]. Bone marrow-derived macrophages
(BMDMs) were obtained from Mavs
+/+ and Mavs
2/2 littermate
mice, and cultured in DMEM containing 10% FBS and 10% L929
cell-conditioned medium for 6 days before viral infection. cHV68
K3/GFP was kindly provided by Dr. Philip Stevenson (Cambridge
University, UK). Wild-type cHV68 and cHV68 K3/GFP were
amplified in NIH 3T3 cells, and viral titer was determined by a
plaque assay using NIH 3T3 monolayer. Sendai virus (SeV) stock
(Charles River Laboratories) is 4000 HA units/ml.
Mice and Infections
Wild-type (Mavs
+/+) and knockout (Mavs
2/2) mice were
described previously [23]. Gender-matched, 6- to 8-week-old
littermate mice were intranasally inoculated with 40 plaque-
forming units (PFU) of wild-type cHV68. To assess cytokine
production in the lung, gender- and age-matched BL/6 mice
(ARC, UT Southwestern Medical Center) were intranasally
infected with 1610
5 PFU of cHV68. To assess the antiviral effect
of IL6 and TNFa, BL/6 mice were intranasally infected with
40 PFU of cHV68, and recombinant mouse IL6 and TNFa
(rmIL6 and rmTNFa, PeproTech) were intranasally administered
in 30 ml of 1% BSA (Sigma) in PBS from 1 to 5 days post-infection
(d.p.i.) (30 ng/mouse/day). Mouse lungs were harvested at 6 d.p.i.
and homogenized in DMEM.
Determining the Delivery Efficiency of Intranasal
Administration
To determine the delivery efficiency of intranasal administration
of cytokines, 1610
9 relative light units (RLU) of firefly luciferase
was diluted in 15 mlo r3 0ml buffer (1% BSA in PBS). BL/6 mice
were anaesthetized by intraperitoneally injecting a cocktail of
ketamine and xylazine. Buffer alone or luciferase solution was
intranasally administrated. Mouse tissues (nasal cavity, trachea,
and lung) were harvested at 2 hours post administration, and
homogenized by bead-beating in 300 ml passive lysis buffer
(Promega). Luciferase activity was immediately quantified with
the Luciferase Assay System (Promega). The delivery efficiency of
intranasal administration was assessed by analyzing the relative
luciferase activity in the lung.
Cytokine ELISA
Commercial cytokine ELISA kits used in this study include: IL6
(BD Bioscience), IL10 (BD Bioscience), TNFa (BD Bioscience),
CCL5 (PeproTech), and CXCL1 (R&D Systems). Cytokine levels
in mouse tissue samples or the supernatant from cultured cells
were assessed according to manufacturer’s instruction. Absorbance
was read by FLUOstar Omega (BMG Labtech.).
Plaque Assay
Viral titer of mouse tissues or cell lysates was assessed by a
plaque assay on NIH 3T3 monolayer essentially as previously
described [22]. Briefly, after three rounds of freezing and thawing,
10-fold serially-diluted virus-containing supernatant was added
onto NIH 3T3 cells and incubated for 2 hours at 37uC. Then,
DMEM containing 2% NCS and 0.75% methylcellulose (Sigma)
was added after removing the supernatant. Plaques were counted
at day 6 post-infection. The detection limit for this assay is 5 PFU.
To assess the antiviral effect of IL6 and TNFa, wild-type MEFs
were plated at an initial cell density of 5,000 cells/cm
2, and
infected with cHV68 at a multiplicity-of-infection (MOI) of 0.005.
DMEM containing 2 ng/ml rmIL6 or rmTNFa were added to
cells at 2 hours before infection. Medium was removed at 2 hours
post-infection, and cells were washed with medium and incubated
in DMEM containing 2% FBS and 0.75% methylcellulose.
Plaques were counted at day 5 post-infection.
Histology
Mavs
+/+ and Mavs
2/2 littermate mice were intranasally infected
with 40 PFU of cHV68 as described above. Mouse right lungs
were fixed in the neutral buffered 10% formalin solution (Sigma)
overnight at 4uC. Tissue specimens were dehydrated, embedded in
paraffin, and cut into 3 mm sections. Lung sections were analyzed
by hematoxylin and eosin (H&E), immunohistochemistry, and
cytochemistry staining. Macrophages were stained with rabbit
anti-Iba1 polyclonal antibody (Wako), rabbit ABC staining system
(Santa Cruz), and DAB substrate kit (Vector laboratories).
Neutrophils were stained with the Naphthol AS-D Chloroacetate
Specific Esterase Kit (Sigma). Hematoxylin solutions for counter-
taining include: Gril No. 2 for macrophage staining, and Gril
No. 3 for neutrophil staining.
Reverse Transcription (RT)-PCR and Quantitative Real-
Time PCR (qRT-PCR)
To determine the relative levels of cytokine transcripts, RT-
PCR and qRT-PCR were performed as previously reported [22].
Briefly, total RNA was extracted from MEFs or mouse tissues
using TRIzol reagent (Invitrogen). To remove genomic DNA,
total RNA was digested with RNase-free DNase I (New England
Biolab) at 37uC for 1 hour. After heat inactivation, total RNA was
re-purified with TRIzol reagent. cDNA was prepared with 1.5 mg
total RNA and reverse transcriptase (Invitrogen). RNA was then
removed by incubation with RNase H (Epicentre). The abundance
of cytokine mRNAs and viral transcripts was assessed by qRT-
PCR using 7500 Fast Real-Time PCR system (Applied Biosys-
tems). Mouse b-actin was used as an internal control. All primers
were designed by Primer Express 3.0 (Applied Biosystems) and
validated individually (Table S1).
Nuclear Extraction and Electrophoresis Mobility Shift
Assay (EMSA)
MEFs were infected with cHV68 K3/GFP (MOI=5), and
harvested at indicated time points. Cells were washed once with
ice-cold PBS, scrapped into 5 ml cold PBS on ice, and
centrifuged at 2,000 g, 4uC for 5 min. Cell pellets were
resuspended in ice-cold hypotonic lysis buffer (10 mM Tris-HCl
[pH 7.4], 150 mM NaCl, 1.5 mM MgCl2, 0.5 mM phenyl-
methylsulfonyl fluoride, 10 mM dithiothreitol, 0.65% Nonidet P-
40). Nuclei were spun down and rinsed with ice-cold hypotonic
lysis buffer without Nonidet P-40. Nuclei were resuspended in a
low salt buffer (20 mM HEPES [pH 7.9], 2 mM EDTA
[pH 8.0], 20 mM KCl, 1.5 mM MgCl2, 0.5 mM phenylmethyl-
sulfonyl fluoride, 0.5 mM dithiothreitol, 25% glycerol). Then, a
high salt buffer (20 mM HEPES [pH 7.9], 2 mM EDTA
[pH 8.0], 800 mM KCl, 1.5 mM MgCl2, 0.5 mM phenylmethyl-
sulfonyl fluoride, 0.5 mM dithiothreitol, 25% glycerol) was added
in a dropwise fashion while stirring gently. The supernatant
(nuclear extract) was collected by centrifugation at 25,000 g for
30 min at 4uC.
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Two micrograms of nuclear extracts were incubated with a
32P-
labeled oligonucleotide (Promega) containing the NFkB consen-
sus site (59-AGT TGA GGG GAC TTT CCC AGG C-39) for 15
minutes at room temperature in a binding reaction containing
10 mM Tris-HCl (pH 7.5), 0.5 mM EDTA, 50 mM NaCl,
1m MM g C l 2, 0.5 mM dithiothreitol, 0.05 mg/ml poly(dI-dC)
(Sigma), 4% glycerol. For the competition assay and the super-
shift assay, 50-fold molar excess of cold probe or 20 mg/ml (final
concentration) mouse monoclonal anti-RelA (sc-8008, Santa
Cruz Biotech.) was separately pre-incubated with nuclear extracts
for 10 min before adding the
32P-labeled probe. DNA-protein
complexes were subjected to electrophoresis in 6% native
polyacrylamide gels (0.25 6 TBE) at a constant current of
9 mA. Gels were dried and analyzed by STORM 820
(Amersham Bioscience) for autoradiography.
Establishing Stable Cell Lines
Lentivirus production in 293T cells was carried out as
previously described [22]. Briefly, 293T cells were co-transfected
with the packaging plasmids (VSV-G and DR8.9) and pCDH
derived plasmids expressing Flag-tagged IkBaDN, wild-type
RelA, or the S468A RelA variant carrying the Serine 468-to-
Alanine mutation. At 72 hours post-transfection, supernatant was
collected and passed through 0.45 mm filter. Mouse embryonic
fibroblasts (MEFs) were infected with filtered lentivirus in
complete DMEM containing 10 mg/ml polybrene. To maximize
the infection efficiency, cells were centrifuged at 1,800 rpm, 30uC
for 1 hour, and incubated at 37uC up to 6 hours. MEFs were
selected and maintained in complete DMEM containing 1 mg/ml
puromycin.
Confocal Microscopy
To assess RelA nuclear translocation, control wild-type MEFs
or those stably expressing the Flag-tagged IkBaDN were treated
with 10 ng/ml TNFa for 30 minutes, or infected with cHV68
K3/GFP (MOI=5). Thirty minutes later, cHV68-infected cells
were treated with 20 mM MG132 for 2 hours or left untreated.
Cells were fixed, permeabilized, stained with rabbit anti-RelA
antibody and Alex 596-congugated goat anti-rabbit secondary
antibody, and analyzed with confocal microscope (Leica).
Immunoprecipitation and Immunoblot
Immunoprecipitation and immunoblot were as previously
described [22,55]. Briefly, cells were harvested, rinsed once with
ice-cold PBS, and resuspended with RIPA buffer (50 mM Tris-
HCl [pH 7.4], 150 mM NaCl, 0.5% sodium deoxycholate, 0.1%
SDS, 1% NP40, 5 mM EDTA/EGTA) supplemented with
protease inhibitor cocktail. Centrifuged supernatant was pre-
cleared with protein A/G agarose at 4uC for one hour, and
subjected to precipitation by incubating with anti-RelA antibody
and protein A/G agarose, or anti-Flag M2-conjugated agarose.
Precipitated proteins were extensively washed with RIPA buffer
and eluted with 16SDS-PAGE loading buffer by boiling at 95uC
for 5 - 10 min.
For immunoblot analysis, WCLs (20 mg) or precipitated proteins
were resolved by SDS-PAGE, and transferred to PVDF
membrane. Immunoblot detection was performed with corre-
sponding primary antibodies as indicated by incubating at 4uC
overnight and with secondary peroxidase-conjugated antibody for
one hour. Proteins were visualized with SuperSignal West Pico
Chemiluminescent Substrate (Thermo Scientific) and a Fujifilm
LAS-3000 imaging system (FujiFilm).
Antibodies
Commercial antibodies used in this study include: anti-Flag
(Sigma), anti-IkBa (sc-371, Santa Cruz Biotech.), rabbit anti-RelA
(sc-372-G, Santa Cruz Biotech.), mouse anti-RelA (sc-8008, Santa
Cruz Biotech.), anti-RelA S536p (93H1, Cell Signaling), anti-RelA
S468p (Bethyl Group), anti-b-actin (Abcam.), anti-ubiquitin-
conjugated protein (FK2, Affiniti Research Products), and anti-
Iba1 (Wako).
Statistical Analysis
The statistical significance (P-value) is calculated by unpaired
two-tailed Student’s t-test. *, P,0.05; **, P,0.02; ***, P,0.005.
A P-value of ,0.05 is considered statistically significant.
NCBI Entrez Gene ID (Mus musculus) List
RIG-I, 230073; MDA-5, 71586; MAVS, 228607; TBK1,
56480; IKKe, 56489; IRF3, 54131; IRF7, 54123; c-Jun, 16476;
ATF-2, 11909; p300, 328572; IFNb, 15977; IKKc, 16151; IKKa,
12675; IKKb, 16150; IkBa, 18035; NFkB1, 18033; RelA, 19697;
NFkB2, 18034; RelB, 19698; c-Rel, 19696; IL6, 16193; TNFa,
21926; CCL5, 20304; CXCL1, 14825; IL10, 16153.
Supporting Information
Figure S1 Cytokine levels of cHV68-infected Mavs
+/+
and Mavs
2/2 littermates. Age- and gender-matched Mavs
+/+
and Mavs
2/2 littermate mice (eight mice per group) were
intranasally infected with 40 plaque-forming units (PFU) of
cHV68. Cytokine levels in the serum (A) or the lung (B) of
cHV68-infected mice were determined by ELISA. (A) There was
no significant difference of serum cytokines (except CCL5 at 10
and 16 days post-infection) between Mavs
+/+ and Mavs
2/2
littermates. (B) There was no significant difference of anti-
inflammatory cytokine IL10 in the lung between Mavs
+/+ and
Mavs
2/2 littermates. Data are presented as the mean 6 the
standard error of the mean (SEM) of eight mice. The statistical
significance: **, P,0.02.
(PDF)
Figure S2 Intranasal administration using a total
volume of 30 ml efficiently delivers protein into mouse
lung. To assess the delivery efficiency of protein, buffer (1% BSA
in PBS) alone and firefly luciferase diluted in 15 mlo r3 0ml buffer
were intranasally administered to BL6 mice (five to six mice per
group). (A) Mouse tissues (nasal cavity, trachea, and lung) were
harvested and homogenized at 2 hours post administration. (B)
Relative luciferase activity in the trachea and the lung was
normalized to that in the nasal cavity. Each symbol represents one
mouse. The statistical significance: ***, P,0.005. (C) The
distribution percentage of firefly luciferase among the nasal cavity,
trachea, and lung. Data are presented as the mean 6 SEM.
(PDF)
Figure S3 Intranasal administration of recombinant
mouse IL6 or TNFa does not affect mouse health. Age-
and gender-matched BL/6 mice were intranasally infected with
40 PFU of cHV68 (eight mice per group). Buffer (1% BSA in PBS)
alone, recombinant mouse IL6 or TNFa (rmIL6 or rmTNFa,
30 ng/mouse/day) were intranasally administered from 1 to 5
days post-infection (d.p.i.). All mice were sacrificed at 6 d.p.i. (A)
Body weight of all mice was recorded during the entire
experimental period. Each cross (6) represents one mouse. There
was no significant gain or loss of the body weight among the mock-,
rmIL6-, or rmTNFa-treated mice. (B) Spleen mass was measured
at 6 d.p.i. There was no significant difference of spleen size or
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and D) IL6 and TNFa levels in the lung at 6 d.p.i. were
determined by ELSIA. Data in (B), (C) and (D) are presented as
the mean 6 SEM of eight mice. The statistical significance:
**, P,0.02.
(PDF)
Figure S4 Deficiency in MAVS results in an elevated
immune cell infiltration in the lung of cHV68-infected
mice. Age- and gender-matched Mavs
+/+ and Mavs
2/2
littermate mice were intranasally infected with 40 PFU of
cHV68. At 10 days post-infection, mouse lungs were fixed and
embedded in paraffin. Three-micrometer sections were ana-
lyzed by hematoxylin and eosin (H&E) staining (A), immuno-
histochemistry staining (B and C), and cytochemistry staining
(D). Pictures were taken at the magnification of 200. One to
three optical fields are presented for each group. (A) H&E
staining of paraffin sections demonstrated a mild mixed-cell
infiltration (lymphocytes and macrophages dominant, and
neutrophils rare) causing diffuse increased interstitial cellularity
(black arrowhead) in the lungs of cHV68-infected Mavs
+/+ mice.
In the lungs of cHV68-infected Mavs
2/2 mice, there was an
intense peribronchial and perivascular immune infiltration
(black arrow) .A ,a i r w a y ;V ,b l o o dv e s s e l .( Ba n dC )P u l m o n a r y
macrophages were probed with anti-Iba1 antibody. (B) The
negative control was set up for all sections. One representative
positively stained optical field was shown in comparison to its
negative control. (C) cHV68 infection induced more peribron-
chial and perivascular macrophage infiltrates in Mavs
2/2 mice
than those in Mavs
+/+ mice. (D) Pulmonary neutrophils (red
arrowheads) were selectively stained by an esterase specific assay.
cHV68 infection induced a significant increase of perivascular
neutrophils in the lungs of Mavs
2/2 mice, but not in those of
Mavs
+/+ mice.
(PDF)
Figure S5 Deficiency in MAVS impairs Sendai virus
(SeV)-induced cytokine production by bone marrow-
derived macrophages (BMDMs). BMDMs from Mavs
+/+ and
Mavs
2/2 littermate mice were infected with 500 HA units of
Sendai virus for 12 hours. Cytokine levels in the supernatant were
determined by ELISA. Data are presented as the mean 6 SEM
of three independent experiments. The statistical significance:
**, P,0.02; ***, P,0.005.
(PDF)
Figure S6 cHV68 slightly reduces cytokine levels in the
lung during early infection in vivo. Age- and gender-
matched BL6 mice (five mice per group) were intranasally infected
with 1610
5 PFU of cHV68. Cytokine Levels (IL6, TNFa, CCL5
and CXCL1) in the lungs of mock- or cHV68-infected BL6 mice
at 2.5 days post-infection were determined by ELISA (A) or
quantitative real-time PCR (qRT-PCR) using b-actin as an
internal control (B). Each symbol represents one mouse. (A)
cHV68 infection slightly reduced cytokine levels in the lung. The
statistical significance: *, P,0.05. (B) To quantify viral lytic
replication in the lung of cHV68-infected mice, RTA mRNA
levels were determined by qRT-PCR. Red dashed lines represent
the trend lines of regression between mRNA levels of cytokines
and those of cHV68 RTA. The r stands for Pearson product-
moment correlation coefficient between mRNA levels of cytokines
and those of cHV68 RTA.
(PDF)
Figure S7 MAVS deficiency impairs cHV68-induced
IFNb expression in mouse embryonic fibroblasts
(MEFs). Mavs
+/+ and Mavs
2/2 MEFs were infected with
cHV68 at an MOI of 5. Cells were collected at indicated time
points, and IFNb mRNA levels were determined by real-time
PCR using b-actin as an internal control. Data are presented as
the mean 6 SEM of three independent experiments. The
statistical significance: *, P,0.05; **, P,0.02.
(PDF)
Figure S8 cHV68 fails to induce cytokine response in
mouse embryonic fibroblasts (MEFs) deficient in IKKb
or IKKc. See also Figure 4B. Wild-type MEFs, or those deficient
in MAVS, IKKb or IKKc were infected with cHV68 (MOI=5).
Relative quantity of cytokine mRNAs in cHV68-infected MEFs
were analyzed by real-time PCR and normalized to that of b-
actin.
(PDF)
Figure S9 NFkB activation in Mavs
+/+ and Mavs
2/2
mouse embryonic fibroblasts (MEFs) by electrophoresis
mobility shift assay. Mavs
+/+ and Mavs
2/2 MEFs were
incubated with buffer alone (negative control) or 10 ng/ml TNFa
for 30 minutes (positive control). Nuclear extracts (2 mg) were
subjected to electrophoresis mobility shift assay using a [
32P]-
NFkB probe, without or with pre-incubating with cold NFkB
probe or a monoclonal anti-RelA antibody.
(PDF)
Figure S10 Expression of IkBaDN blocks nuclear trans-
location of RelA. Wild-type mouse embryonic fibroblasts
(MEFs) stably expressing the Flag-tagged IkBa super-suppressor
(IkBaDN) were established as described in Materials and
Methods. MEFs were treated with 10 ng/ml TNFa,f i x e d ,a n d
permeabilized. Cells were stained with rabbit anti-RelA
antibody and Alex 596-congugated goat anti-rabbit secondary
antibody, analyzed with confocal microscope (Leica). A
representative field was shown for each time point. The
percentage of cells showing RelA nuclear translocation was
calculated based on 200 cells.
(PDF)
Figure S11 IKKa deficiency does not impair cHV68-
induced RelA degradation. Wild-type and IKKa-deficient
MEFs were infected with cHV68 at an MOI of 20 and cells were
harvested at indicated time points. Whole cell lysates were
analyzed by immunoblot with antibodies to RelA and actin.
(PDF)
Figure S12 Expression of RelA.S468A variant impairsc
HV68 lytic replication in mouse embryonic fibroblasts
(MEFs). Control (Vector), and wild-type MEFs expressing
RelA.S468A-expressing or IkBaDN were infected with cHV68
at a multiplicity-of-infection (MOI) of 0.01 (A) or 0.005 (B). (A)
Viral titer in the supernatant collected at 1 d.p.i. and 2 d.p.i. was
determined by a plaque assay. (B) At 2 hours post-infection,
supernatant was replaced with fresh DMEM containing 2% FBS
and 0.75% methylcellulose. Plaques formed in MEF monolayers
were counted at 6 d.p.i. Data in (A) and (B) are presented as the
mean 6 SEM of three independent experiments. The statistical
significance: *, P,0.05.
(PDF)
Table S1 Primer list. PCR primers were designed by
MacVector 9.0 (Accelrys Inc.), and quantitative real-time PCR
(qRT-PCR) primers were designed by Primer Express 3.0 (Applied
Biosystems). All primers used in this study were synthesized by
Invitrogen.
(PDF)
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